iShares 1 3 Year Treasury Bond ETF vs Veeva Systems — how do they compare? iShares 1 3 Year Treasury Bond ETF trades at $81.19 (market cap $26.68B), while Veeva Systems trades at $285.1 (market cap $46.12B). The key difference: Veeva Systems is the larger of the two by market cap, and Veeva Systems is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares 1 3 Year Treasury Bond ETF for 63 Days and Veeva Systems for 5 Days on average.
| SHY | VEEV | |
|---|---|---|
Market Cap | $26.68B | $46.12B |
Volume | 4,077,691 | 921,537 |
Sector | Fixed Income | Technology |
52-Week High | $83.18 | $299.10 |
52-Week Low | $81.05 | $151.43 |
Typical Hold Time | 63 Days | 5 Days |
Enterprise Value | — | $39.03B |
Signals from Pluang's Aura AI — not financial advice
SHY, a US stock, trades at $81.16, up 0.04% on the day. Technical indicators are bearish, with moving averages signaling sell pressure and oscillators neutral. The stock faces resistance and support near $81. Recent corporate actions include dividend payments, with the latest at $0.24 per share. Financial ratios are unavailable in the provided data, limiting fundamental analysis.
The outlook for SHY is cautious due to bearish technical signals and a lack of current fundamental data. Investment opportunities may arise from dividend income, but risks include market volatility and reliance on broader economic conditions. Investors should seek updated financials for a complete assessment.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →